Compliance approval Sample Clauses

Compliance approval. Promoting of Marks and Platforms, which are subject of regulation, shall be pre-approved by Company before the promoting starts, as well as content and any amendments/updates to it. In case the content was amended/updated by the Affiliate without obtaining the Company’s preliminary approval the Company may, at its sole and exclusive discretion, terminate the Agreement in respect of the Affiliate. Affiliate fee will not be paid for all the traders you referred to us and who registered while promoting Marks and Platforms in violation of these conditions.
Sample 1Sample 2Sample 3See All (6)
AutoNDA by SimpleDocs
Compliance approval. The Mortgage Lender may submit the Compliance Package to the Authority at any time after the Mortgage Loan reservation. The Authority will review the Compliance Package and either approve such Mortgage Loan or communicate any conditions that must be resolved to the Mortgage Lender. The Mortgage Lender may choose to close and fund the Mortgage Loan prior to receiving the Authority’s approval of the Compliance Package; provided, however, that the Mortgage Loan will not be eligible to be purchased by the Servicer unless and until the Authority has approved the Compliance Package.
Sample 1Sample 2Sample 3See All (6)
Compliance approval. Promoting of Marks and Platforms, which are subject of regulation, shall be pre-approved by Libertex before the promoting starts, as well as content and any amendments/updates to it. In case the content was amended/updated by the Affiliate without obtaining the Libertex’s preliminary approval, the Company may, at its sole and exclusive discretion, terminate the Agreement in respect of the Affiliate. Affiliate fee will not be paid for all the traders you referred to us and who registered while promoting Marks and Platforms in violation of these conditions.
Sample 1
Compliance approval. (Please print) Name: ............................................................................................................................................ Signature: ................................................................................................................................... Date: ............................................................. Terms of Agreement
Sample 1
Compliance approval. This Note and Security Agreement is subject to compliance with SEC Rules and Regulations and has been approved by the shareholder of Payee.
Sample 1

Related to Compliance approval

  • Regulatory Compliance a. Monitor compliance with the 1940 Act requirements, including:

  • FDA Compliance The Company: (A) is and at all times has been in material compliance with all statutes, rules or regulations of the FDA and other comparable governmental entities applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product under development, manufactured or distributed by the Company (“Applicable Laws”); (B) has not received any FDA Form 483, notice of adverse finding, warning letter, untitled letter or other correspondence or notice from the FDA or any governmental entity alleging or asserting material noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, exemptions, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (“Authorizations”); (C) possesses all material Authorizations and such Authorizations are valid and in full force and effect and the Company is not in material violation of any term of any such Authorizations; (D) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from the FDA or any governmental entity or third party alleging that any product operation or activity is in material violation of any Applicable Laws or Authorizations and has no knowledge that the FDA or any governmental entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (E) has not received notice that the FDA or any governmental entity has taken, is taking or intends to take action to limit, suspend, modify or revoke any material Authorizations and has no knowledge that the FDA or any governmental entity is considering such action; and (F) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were materially complete and correct on the date filed (or were corrected or supplemented by a subsequent submission).

  • Compliance Program The Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or EMA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.

  • Regulation M Compliance The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company’s placement agent in connection with the placement of the Securities.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!